Likewise, the inflammatory chemokine CCL5, interacting primarily with G protein-coupled receptor CCR5, is highly expressed in several cancers, including breast cancer, and has been shown to play an important pro-oncogenic role via immune cell recruitment, tumor growth, chemotaxis, and apoptosis [59–61]. This evidence concerns the gene CCL5 and breast cancer.